Epidemiology and impact of hepatitis B virus on haemato-biochemical parameters in patients in Conakry (Republic of Guinea).

Authors

  • Dr Taliby Dos CAMARA 1. Biology Laboratory, Biology Laboratory, Faculty of Science, Gamal Abdel Nasser University of Conakry, BP : 1147 Republic of Guinea 2. Laboratory at the ‘Roger Santoni’ Medical Centre in Kobayah, Commune of Ratoma, Conakry, Republic og Guinea 3. Biomedical analysis laboratory Alouse CO Guinea, Commune of Dixinn, Conakry-Republic of Guinea 4. Biomedical analysis laboratory at the Ratoma Communal Medical Centre, Conakry-Republic of Guinea 5. Medical Biology Laboratory, Mahatma Gandhi University, Guinea Author

Keywords:

Hepatitis B, Haematology, Biochemistry, Epidemiology, Conakry

Abstract

Introduction: Infection with the hepatitis B virus is a major public health problem worldwide. There are an estimated 350 million chronic HBsAg carriers worldwide. Objective: To determine the prevalence of HBV and hepatic and blood disorders by testing for HBsAg and measuring transaminases in patients at health facilities in Conakry. Method : This is a prospective, descriptive, cross-sectional study covering a six-month period from 1 July to 1 December 2022. Results : Serodiagnosis of the hepatitis B virus in 746 patients in Conakry revealed 101 positive cases, i.e. a prevalence of 14%, compared with 645 negative cases, i.e. 86%. 78% of patients had haemoglobin levels <12 g/dl, with the following anaemic typology: 61% had a haemoglobin level between 10 and 11 g/dl (a sign of frustrated anaemia), 34% had a haemoglobin level between 8 and 9 g/dl (a sign of moderate anaemia) and 5% had a haemoglobin level ≤ 7 g/dl (a sign of severe anaemia); 42% of patients had low lymphocytes, 26% low monocytes, 19% low neutrophils and 14% low leukocytes. While 30% of patients had hyperleukocytosis and 31% hyperlymphocytosis. The transaminase assay showed that 75% of patients had increased ALT levels and 66% had increased ASAT levels.. Married people were the most represented with a prevalence of 68% against 32% of single people. The female sex was the most affected with 80% against 20% for the male sex. Almost all socio-professional categories were affected by hepatitis B with a predominance of Housewives with 26/101, i.e. 26%, followed by Workers with 19/101, i.e. 19%, Commercial and Administrative workers with 18%, Pupils/Students with 17%. The age group between 31-40 years with 36% followed by 21-30 years with 35% were the most represented in this study. The commune of Ratoma is the most represented with 60%, followed by Dixinn with 17% and the commune of Matoto with 12%. Conclusion : Hepatitis B is a major public health problem and in order to improve the management of patients, the determination of haematological parameters is necessary.

Author Biography

  • Dr Taliby Dos CAMARA, 1. Biology Laboratory, Biology Laboratory, Faculty of Science, Gamal Abdel Nasser University of Conakry, BP : 1147 Republic of Guinea 2. Laboratory at the ‘Roger Santoni’ Medical Centre in Kobayah, Commune of Ratoma, Conakry, Republic og Guinea 3. Biomedical analysis laboratory Alouse CO Guinea, Commune of Dixinn, Conakry-Republic of Guinea 4. Biomedical analysis laboratory at the Ratoma Communal Medical Centre, Conakry-Republic of Guinea 5. Medical Biology Laboratory, Mahatma Gandhi University, Guinea

    [1] WHO E. Management of hepatitis B and HIV co-infection. Copenhagen: WHO Regional Office for Europe. 2011.

    [2] Aurpibul L, Lumbiganon P, Kolasaraksa P, et al. HIV and Hepatitis B Co-infection Among Perinatally HIV-infected Thai Adolescents. Pediatr Infect Dis J. 2012;31(9):943-947.

    [3] Kye Duodu G, Nortey P, Malm K, et al. Prevalence of Hepatitis B virus co-infection among HIV-seropositive persons attending antiretroviral clinics in the Eastern Region of Ghana. The Pan African Medical Journal. 2016 ;25 (Supp1):7.

    [4] Abdoulaye Makanéra,Taliby Dos Camara, Mariam Condé, Fatoumata Djalikatou Bah, Mamadou Alpha Diallo, Alpha Oumar Barry, Daouda Camara, Tiguidanké Diakité. Hepatitis B virus infection and risk factors for hepatocarcinoma hepatocarcinoma at the Kipé China-GuineaChina-Guinea Friendship Hospital in Conakry. International Clinical Pathology Journal. Volume 9 Issue 1 - 2022;9(1):30-33. 

    [5] André F. Epidemiology of hepatitis B in Asia, the Middle East and Africa. Vaccine. 2000;18(Suppl. 1):S20-22.

    [6] Lejeune O. La maladie In: Trépo C, Merle P, Zoulim F, editors. Hépatites virales B et C Paris : John Libbey Eurotext. 2006;149-161.

    [7] Fattovich G. Natural history and prognosis of hepatitis B. Semin Liver Dis. 2003;23(1):47-58.

    [8] Barth RE. Hepatitis B/C and HIV in sub-Saharan Africa: an association between highly prevalent infectious diseases. A systematic review and meta-analysis. Int J Infect Dis. 2010;14(12):1024-1031.

    [9] Mandiwana A, Tshitenge S. Prevalence of human mmunodeficiency virus- hepatitis B virus co-infection among adult patients in Mahalapye, Ngami, Serowe, Botswana:a descriptive cross-sectional study. South African Family Practice. 2017;59(3):94-97.

    [10] WHO. Prevalence of hepatitis B virus infection worldwide by country. 2016.

    [11] Diop M, DIOUF A, Malaobé S, Lo G, Ka D, Massaly A, et al. Prevalence of hepatitis B virus surface antigen and associated factors in Senegalese soldiers sent on mission to Darfur. Pan African Medical Journal. 2017;26:154.

    [12] Eloumou SAFB, Luma HN, Noah DN, et al. Clinicopathological characteristics of a group of sub-Saharan African patients with chronic hepatitis B virus infection: A Gender Analysis. Gastroenterol Hepatol Open Access. 2016;5(8):00174.

    [13] Montella M, D'Arena G, Crispo A, et al. Role of sex hormones in the development and progression of hepatitis B virus:associated hepatocellular carcinoma. Int J of EndocrinoL. 2015;2015:854530.

    [14] Dao S, Bougoudogo F, Traoré S, ET AL. Le portage de l'Ag HBs au Mali : Bilan de dix ans de dépistage à l'Institut national de recherche en santé publique (INRSP). J Afr Cancer. 2009;1(2):68-71.

    [15] Kra O, N'diri N, Ouattara B, et al. Prévalence du portage de l'antigène HBs dans une population de recrues de la gendarmerie nationale de Côte d'Ivoire en 2008. Med Santé trop. 2012;22(2):219-220.

    [16] Agbenu E, Banla A, Kolou M, et al. Marqueurs sérologiques utilisés pour la surveillance de l'hépatite B au Togo : Etat des lieux et propositions d'actions. Med Trop. 2008;68(6):621-624.

    [17] Katilé D, Konaté I, Goita D, et al. Prévalence de l'antigène HBs et profil sérologique des patients atteints d'hépatite B vus en consultation de médecine générale dans un hôpital régional du Mali : le cas de l'hôpital de Kayes. Health Sci Dis. 2018;19(4).

Downloads

Published

2025-03-07

How to Cite

Epidemiology and impact of hepatitis B virus on haemato-biochemical parameters in patients in Conakry (Republic of Guinea). (2025). International African Review of Multidisciplinary Sciences (IARMS), 1(1), 1-6. https://sciencejournalhub.org/index.php/IARMS/article/view/13